logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
郑亮 封面图

郑亮 (Liang Zheng)

Anhui Medical University

24H指数
89论文数
2.0K被引数
收录论文 36
发表时间
logo
Development of a generic physiologically based pharmacokinetic model to predict clinical pharmacokinetics and assess drug-drug interaction risks for vcMMAE-based antibody-drug conjugates开发一种通用生理药代动力学模型，以预测临床药代动力学并评估vcMMAE抗体药物偶联物的药物-药物相互作用风险
errDrug Metabolism and Disposition
IF4
err2026-04-01
err0
PREAI
errChaozhuang Shen; Rui Wang; Jiapin Yan; Liang Zheng; Haitang Xie; Xuehua Jiang; Ling Wang
err分享
err收藏
Model-Informed Evidence for Rifapentine Use in Chinese HIV-Positive Adults with Latent Tuberculosis: Assessing Ethnic PK Differences and Interactions with Ritonavir基于模型证据探讨利福喷丁在中国HIV阳性潜伏结核患者中的应用：评估种族药代动力学差异及与利托那韦的相互作用
errInternational Journal of Infectious Diseases
IF4.3
err2025-11-15
err0
errOAAI
errHongyi Yang; Weijian Liu; Nuo Xu; Wei Li; Wen Yao Mak; Chaozhuang Shen; Liang Zheng; Qingfeng He; Yehua Xie; Xiaoqiang Xiang; Peize Zhang; Xiao Zhu
err分享
err收藏
Safety, tolerability, pharmacokinetics, immunogenicity, and pharmacodynamics of MG-ZG122, a long-acting humanized anti-thymic stromal lymphopoietin mAb, in healthy Chinese: a randomized, double-blind, placebo-controlled, dose-escalation, phase I study安全性、耐受性、药代动力学、免疫原性和药效动力学评价：MG-ZG122（一种长效人源化抗胸腺基质淋巴细胞生成素单克隆抗体）在中国健康受试者中的研究——一项随机、双盲、安慰剂对照、剂量递增的I期临床研究
errExpert Opinion on Investigational Drugs
IF4.1
err2025-10-30
err0
PREAI
errXuan Zhang; Lingqiao Zhu; Qian Zhang; Liang Zheng; Jinlin Guo; Qiuling Zou; Rui Yan; Di Qin; Chenghai Zhang; Wei Hu
err分享
err收藏
Phase I study of the oral GLP-1 receptor agonist DA-302168S: Safety, pharmacokinetics, and pharmacodynamics in healthy and overweight/obese adultsI期研究：口服GLP-1受体激动剂DA-302168S在健康和超重/肥胖成年人群中的安全性、药代动力学和药效学评价
errDiabetes, Obesity and Metabolism
IF0
err2025-09-24
err0
PREAI
errLiang Zheng PhD; Yuanxun Yang MM; Guangxin Dong PhD; Xiaolong Qin BM; Wenwen Li MM; Yuwen Zhang BM; Haiyan Li MD; Shaofeng Zhang MS; Peng He PhD; Qijun Ye MS; Zhou Yu ME; Yi Li BM; Juan Li PhD; Wei Hu PhD
err分享
err收藏
Physiologically based pharmacokinetic modeling of tapentadol in children to support pediatric dose selection基于生理的药代动力学模型在儿童中对tapentadol的研究，以支持儿科剂量选择
errJOURNAL OF PHARMACEUTICAL SCIENCES
IF3.8
err2025-07-01
err0
PREAI
errWang, Zilong; Yang, Yujie; Cao, Zhihai; Dallmann, Andre; Hu, Wei; Zhang, Wei; Zhang, Qian; Zheng, Liang
err分享
err收藏
Suboptimal practices in harm reporting: a meta-epidemiological study on metrics, recurrence, and exposure duration in clinical trials伤害报告中的次优实践：一项关于临床试验中指标、复发和暴露持续时间的元流行病学研究
errJOURNAL OF CLINICAL EPIDEMIOLOGY
IF5.2
err2025-06-01
err0
PREAI
errHuang, Qiao; Wang, Wen; Zheng, Liang; Shi, Yue-Xian; Ge, Long; Zeng, Xian-Tao
err分享
err收藏
Physiologically Based Pharmacokinetic Modeling of Tofacitinib: Predicting Drug Exposure and Optimizing Dosage in Special Populations and Drug-Drug Interaction Scenarios
errPHARMACEUTICALS
IF4.8
err2025-03-18
err0
errOAAI
errCao, Zhihai; Wang, Zilong; Zhang, Qian; Zhang, Wei; Zheng, Liang; Hu, Wei
err分享
err收藏
Evaluating the drug-drug interactions of SHR4640 on repaglinide and midazolam in healthy subjects
errEXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY
IF3.4
err2024-11-14
err0
PREAI
errCheng, Yuanzhi; Hu, Xiaotong; Pei, Zejun; Zhang, Zhe; Lin, Hongda; Feng, Sheng; Gao, Zhenyan; Ma, Yanlin; Cao, Zhihai; Zhang, Qian; Zheng, Liang; Zhang, Wei; Shen, Kai; Hu, Wei
err分享
err收藏
Folylpolyglutamate synthetase inactivation in relapsed ALL induces a druggable folate metabolic vulnerability
errDRUG RESISTANCE UPDATES
IF21.7
err2024-11-01
err0
PREAI
errLi, Hui; Chen, Yao; Ding, Ming; Liu, Jingjing; Sun, Huiying; Fang, Houshun; Brady, Samuel W.; Xu, Yan; Glaser, Fabian; Ma, Xiaotu; Tang, Yabin; Du, Liang; Wu, Xiaoyu; Wang, Shuxuan; Zhu, Liang; Li, Benshang; Shen, Shuhong; Zhang, Jinghui; Zheng, Liang; Yu, Jiyang; Assaraf, Yehuda G.; Zhou, Bin-Bing S.
err分享
err收藏
Evaluating Drug Interactions between Ritonavir and Opioid Analgesics: Implications from Physiologically Based Pharmacokinetic Simulation
errPHARMACEUTICALS
IF4.8
err2024-05-15
err2
errOAAI
errNi, Liang; Cao, Zhihai; Jiang, Jiakang; Zhang, Wei; Hu, Wei; Zhang, Qian; Shen, Chaozhuang; Chen, Xijing; Zheng, Liang
err分享
err收藏
Physiologically Based Pharmacokinetic Modeling to Unravel the Drug-gene Interactions of Venlafaxine: Based on Activity Score-dependent Metabolism by CYP2D6 and CYP2C19 Polymorphisms
errPHARMACEUTICAL RESEARCH
IF4.3
err2024-03-05
err3
PREAI
errShen, Chaozhuang; Yang, Hongyi; Shao, Wenxin; Zheng, Liang; Zhang, Wei; Xie, Haitang; Jiang, Xuehua; Wang, Ling
err分享
err收藏
Physiologically based pharmacokinetic modeling of ritonavir-oxycodone drug interactions and its implication for dosing strategy
errEUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
IF4.7
err2024-03-01
err5
errOAAI
errZheng, Liang; Zhang, Wei; Olkkola, Klaus T.; Dallmann, Andre; Ni, Liang; Zhao, Yingjie; Wang, Ling; Zhang, Qian; Hu, Wei
err分享
err收藏
Physiologically Based Pharmacokinetic Modeling in Neonates: Current Status and Future Perspectives
errPHARMACEUTICS
IF5.5
err2023-12-12
err5
errOAAI
errZhang, Wei; Zhang, Qian; Cao, Zhihai; Liang, Zheng; Hu, Wei
err分享
err收藏
Enhancing Paclitaxel Efficacy with Piperine-Paclitaxel Albumin Nanoparticles in Multidrug-Resistant Triple-Negative Breast Cancer by Inhibiting P-Glycoprotein
errPHARMACEUTICS
IF5.5
err2023-11-30
err3
errOAAI
errXu, Wenwen; Xiao, Yumeng; Zheng, Liang; Xu, Mingyu; Jiang, Xuehua; Wang, Ling
err分享
err收藏
Physiologically Based Pharmacokinetic Modeling to Simulate CYP3A4-Mediated Drug-Drug Interactions for Pyrotinib基于生理的药代动力学模型，以模拟吡替尼的CYP3A4-Mediated药物-药物相互作用
errADVANCES IN THERAPY
IF4
err2023-07-16
err2
PREAI
errNi, Liang; Zheng, Liang; Liu, Yueyue; Xu, Wenwen; Zhao, Yingjie; Wang, Ling; Zhang, Qian; Hu, Wei; Chen, Xijing
err分享
err收藏
Identification of immunotherapy-related lncRNA signature for predicting prognosis, immunotherapy responses and drug candidates in bladder cancer
errBMC CANCER
IF3.4
err2023-04-18
err4
errOAAI
errHui, Pengyu; Ni, Feng; Zheng, Liang; Jia, Lei; Wang, Zhe
err分享
err收藏
Proline-rich acidic protein 1 upregulates mitotic arrest deficient 1 to promote cisplatin-resistance of colorectal carcinoma by restraining mitotic checkpoint complex assembly
errJOURNAL OF CANCER
IF3.2
err2023-01-01
err2
errOAAI
errSong, Jintian; Chen, Yigui; Yu, Hui; Zheng, Liang; Wang, Yi; Li, Dan
err分享
err收藏
Physiologically based pharmacokinetic modeling of brivaracetam and its interactions with rifampin based on CYP2C19 phenotypes
errEUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
IF4.7
err2022-10-01
err15
errOAAI
errYang, Hongyi; Yang, Leting; Zhong, Xiaofang; Jiang, Xuehua; Zheng, Liang; Wang, Ling
err分享
err收藏
Pan-Cancer Analysis Identifies Liver Metastases as Negative Predictive Factor for Immune Checkpoint Inhibitors Treatment Outcome
errFRONTIERS IN IMMUNOLOGY
IF5.9
err2021-06-24
err14
errOAAI
errChen, Xiao-Juan; Ren, Aiqun; Zheng, Liang; Zheng, En-Dian; Jiang, Tao
err分享
err收藏
Predictive Value of KDM5C Alterations for Immune Checkpoint Inhibitors Treatment Outcomes in Patients With Cancer
errFRONTIERS IN IMMUNOLOGY
IF5.9
err2021-04-19
err11
errOAAI
errChen, Xiao-Juan; Ren, Ai-Qun; Zheng, Liang; Zheng, En-Dian
err分享
err收藏

研究方向

主要任职科研业绩
合作学者
合作期刊
刘青 封面图
刘青 (Qing Liu)
H 指数: 106 · 论文数: 3.2K
J
Jinghui Zhang
H 指数: 96 · 论文数: 1.0K
J
John L. Zhou
H 指数: 86 · 论文数: 358
Y
Yehuda G. Assaraf
H 指数: 80 · 论文数: 311
赵慧敏 封面图
赵慧敏 (Huimin Zhao)
H 指数: 76 · 论文数: 366
查看更多